Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.38
EXAC's Cash to Debt is ranked higher than
55% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. EXAC: 0.38 )
EXAC' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.38

Equity to Asset 0.80
EXAC's Equity to Asset is ranked higher than
84% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. EXAC: 0.80 )
EXAC' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.88
Current: 0.8

0.39
0.88
Interest Coverage 19.57
EXAC's Interest Coverage is ranked higher than
57% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 235.10 vs. EXAC: 19.57 )
EXAC' s 10-Year Interest Coverage Range
Min: 4.67   Max: 9999.99
Current: 19.57

4.67
9999.99
F-Score: 7
Z-Score: 6.14
M-Score: -2.84
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.44
EXAC's Operating margin (%) is ranked higher than
83% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. EXAC: 10.44 )
EXAC' s 10-Year Operating margin (%) Range
Min: 6.73   Max: 20.53
Current: 10.44

6.73
20.53
Net-margin (%) 6.47
EXAC's Net-margin (%) is ranked higher than
80% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. EXAC: 6.47 )
EXAC' s 10-Year Net-margin (%) Range
Min: 4.3   Max: 11.59
Current: 6.47

4.3
11.59
ROE (%) 8.09
EXAC's ROE (%) is ranked higher than
79% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. EXAC: 8.09 )
EXAC' s 10-Year ROE (%) Range
Min: 5.87   Max: 14.39
Current: 8.09

5.87
14.39
ROA (%) 6.14
EXAC's ROA (%) is ranked higher than
83% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. EXAC: 6.14 )
EXAC' s 10-Year ROA (%) Range
Min: 3.9   Max: 10.56
Current: 6.14

3.9
10.56
ROC (Joel Greenblatt) (%) 13.93
EXAC's ROC (Joel Greenblatt) (%) is ranked higher than
78% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. EXAC: 13.93 )
EXAC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.7   Max: 33.8
Current: 13.93

8.7
33.8
Revenue Growth (3Y)(%) 6.00
EXAC's Revenue Growth (3Y)(%) is ranked higher than
78% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. EXAC: 6.00 )
EXAC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 6   Max: 30.5
Current: 6

6
30.5
EBITDA Growth (3Y)(%) 8.10
EXAC's EBITDA Growth (3Y)(%) is ranked higher than
82% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. EXAC: 8.10 )
EXAC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 2.4   Max: 38.1
Current: 8.1

2.4
38.1
EPS Growth (3Y)(%) 11.90
EXAC's EPS Growth (3Y)(%) is ranked higher than
83% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. EXAC: 11.90 )
EXAC' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.3   Max: 34.6
Current: 11.9

-8.3
34.6
» EXAC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

EXAC Guru Trades in Q4 2013

Mario Gabelli 672,135 sh (-0.25%)
Chuck Royce 987,244 sh (-2.05%)
Jim Simons 23,000 sh (-4.96%)
» More
Q1 2014

EXAC Guru Trades in Q1 2014

Mario Gabelli 666,440 sh (-0.85%)
Chuck Royce 924,019 sh (-6.4%)
Jim Simons 17,800 sh (-22.61%)
» More
Q2 2014

EXAC Guru Trades in Q2 2014

Jim Simons 24,981 sh (+40.34%)
Mario Gabelli 675,440 sh (+1.35%)
Chuck Royce 848,119 sh (-8.21%)
» More
Q3 2014

EXAC Guru Trades in Q3 2014

Jim Simons 25,600 sh (+2.48%)
Chuck Royce 849,697 sh (+0.19%)
Mario Gabelli 665,287 sh (-1.5%)
» More
» Details

Insider Trades

Latest Guru Trades with EXAC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-09-30 Sold Out 0.01%$18.48 - $21.98 $ 22.6813%0
Joel Greenblatt 2013-06-30 New Buy0.01%$17.9 - $20.76 $ 22.6820%15150
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.90
EXAC's P/E(ttm) is ranked higher than
91% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 84.60 vs. EXAC: 19.90 )
EXAC' s 10-Year P/E(ttm) Range
Min: 13.61   Max: 38.52
Current: 19.9

13.61
38.52
P/B 1.52
EXAC's P/B is ranked higher than
88% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. EXAC: 1.52 )
EXAC' s 10-Year P/B Range
Min: 1.11   Max: 4.67
Current: 1.52

1.11
4.67
P/S 1.28
EXAC's P/S is ranked higher than
85% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. EXAC: 1.28 )
EXAC' s 10-Year P/S Range
Min: 0.85   Max: 3.54
Current: 1.28

0.85
3.54
PFCF 16.32
EXAC's PFCF is ranked higher than
94% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 16.32 )
EXAC' s 10-Year PFCF Range
Min: 14.45   Max: 353.86
Current: 16.32

14.45
353.86
EV-to-EBIT 12.74
EXAC's EV-to-EBIT is ranked higher than
94% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. EXAC: 12.74 )
EXAC' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 25.4
Current: 12.74

9.1
25.4
PEG 1.76
EXAC's PEG is ranked higher than
95% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 1.76 )
EXAC' s 10-Year PEG Range
Min: 1.18   Max: 4.5
Current: 1.76

1.18
4.5
Shiller P/E 24.97
EXAC's Shiller P/E is ranked higher than
93% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 24.97 )
EXAC' s 10-Year Shiller P/E Range
Min: 15.71   Max: 53.41
Current: 24.97

15.71
53.41
Current Ratio 4.93
EXAC's Current Ratio is ranked higher than
84% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. EXAC: 4.93 )
EXAC' s 10-Year Current Ratio Range
Min: 1.64   Max: 8.45
Current: 4.93

1.64
8.45
Quick Ratio 2.24
EXAC's Quick Ratio is ranked higher than
73% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. EXAC: 2.24 )
EXAC' s 10-Year Quick Ratio Range
Min: 0.47   Max: 5.4
Current: 2.24

0.47
5.4

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 10.65
EXAC's Price/Net Current Asset Value is ranked higher than
85% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 10.65 )
EXAC' s 10-Year Price/Net Current Asset Value Range
Min: 3.38   Max: 119.95
Current: 10.65

3.38
119.95
Price/Tangible Book 1.72
EXAC's Price/Tangible Book is ranked higher than
92% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. EXAC: 1.72 )
EXAC' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.7
Current: 1.72

1.37
4.7
Price/DCF (Projected) 1.94
EXAC's Price/DCF (Projected) is ranked higher than
89% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 1.94 )
EXAC' s 10-Year Price/DCF (Projected) Range
Min: 0.46   Max: 382.75
Current: 1.94

0.46
382.75
Price/Median PS Value 0.96
EXAC's Price/Median PS Value is ranked higher than
81% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. EXAC: 0.96 )
EXAC' s 10-Year Price/Median PS Value Range
Min: 0.67   Max: 2.44
Current: 0.96

0.67
2.44
Price/Peter Lynch Fair Value 1.84
EXAC's Price/Peter Lynch Fair Value is ranked higher than
97% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 1.84 )
EXAC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65   Max: 4.41
Current: 1.84

0.65
4.41
Price/Graham Number 1.23
EXAC's Price/Graham Number is ranked higher than
94% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. EXAC: 1.23 )
EXAC' s 10-Year Price/Graham Number Range
Min: 0.91   Max: 2.67
Current: 1.23

0.91
2.67
Earnings Yield (Greenblatt) 7.80
EXAC's Earnings Yield (Greenblatt) is ranked higher than
94% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. EXAC: 7.80 )
EXAC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 10.9
Current: 7.8

3.9
10.9
Forward Rate of Return (Yacktman) 10.38
EXAC's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 5.52 vs. EXAC: 10.38 )
EXAC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.9   Max: 15.8
Current: 10.38

2.9
15.8

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Exactech Inc was founded by an orthopaedic surgeon in November 1985, and is incorporated under the laws of the State of Florida. The Company develops, manufactures, markets, distributes and sella orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its U.S. sales and distribution activities are conducted by its wholly owned subsidiary Exactech U.S., Inc. The Companys international development, sales and distribution activities are conducted by its wholly owned subsidiary Exactech International Operations, AG based in Bern, Switzerland. The Company manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida, utilizing modern, highly automated computer aided manufacturing equipment. Its cellular based manufacturing processes, which are organized in groups, or cells, are dedicated to specific product lines to minimize change-over and increase efficiency. To supplement its manufacturing of components, the company has formed strategic alliances with suppliers and business partners to externally manufacture some components. Additionally, the company acquires and distribute other products and services through exclusive agreements, such as its agreement with Tecres S.p.A, (Tecres) and Blue Ortho, SAS (Blue Ortho), and non-exclusive agreements, such as with RTI Surgical, Inc., (RTI), and Biomatlante SARL, (Biomatlante). The company markets its orthopaedic implant products in the United States through Exactech U.S., Inc. that operates through a network of independent sales agencies and direct sales representatives. The company offers its products in all fifty states, Puerto Rico, and the District of Columbia. The Companys competitors in the orthopaedic market are DePuy, Inc., a division of Johnson and Johnson, Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., Stryker Corporation, Smith and Nephew plc, and Biomet, Inc. The Companys operations are subject to numerous and increasingly stringent federal, state and local environmental laws and regulations in the United States and other countries in which they operates.
» More Articles for EXAC

Headlines

Articles On GuruFocus.com
What the Gurus Did This Week - Weekly Update on Guru Real Time Activity Jun 28 2013 
Mario Gabelli Ups His Holdings in EXAC, TWIN and LAYN Jun 28 2013 
comment on EXAC Oct 03 2011 
Exactech Inc. Reports Operating Results (10-K) Mar 16 2011 
Exactech Inc. Reports Operating Results (10-Q) Nov 09 2010 
Chuck Royce’s Top Predictable Companies: MEDNAX, Techne Corp., ITT Educational Services, Exactech May 17 2010 
Exactech Inc. Reports Operating Results (10-Q) May 05 2010 
Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares May 04 2010 
Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares Dec 11 2009 
Exactech Inc. Reports Operating Results (10-Q) Nov 05 2009 

More From Other Websites
Exactech Executive Chairman and Co-Founder Dr. Bill Petty Honored by Florida Gov. Rick Scott Dec 15 2014
Exactech's Equinoxe Shoulder System: 10 Years of Success Nov 18 2014
Industry’s Fastest Growing Shoulder System Marks 10 Years of Improving Patient Outcomes Nov 17 2014
Industry’s Fastest Growing Shoulder System Marks 10 Years of Improving Patient Outcomes Nov 17 2014
Exactech's (EXAC) Octane Elevate to Advance Spine Surgery Nov 14 2014
EXACTECH INC Financials Nov 14 2014
Exactech (EXAC) Down to Strong Sell On Dismal Q3 Results Nov 13 2014
Exactech Launches Octane® Elevate Peek Spacer System For Lumbar Interbody Fusion Procedures Nov 11 2014
Exactech Launches Octane® Elevate Peek Spacer System For Lumbar Interbody Fusion Procedures Nov 11 2014
10-Q for Exactech, Inc. Nov 07 2014
EXACTECH INC Files SEC form 10-Q, Quarterly Report Nov 05 2014
EXACTECH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Oct 21 2014
Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency... Oct 21 2014
Exactech posts 3Q profit Oct 21 2014
Exactech posts 3Q profit Oct 21 2014
Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency... Oct 21 2014
Q3 2014 Exactech Inc Earnings Release - After Market Close Oct 21 2014
EXACTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 16 2014
Exactech Schedules Q3 2014 Earnings Release and Conference Call Oct 13 2014
Exactech Innovations Presented at Recent Key Scientific Conferences Oct 09 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK